Contineum Therapeutics, Inc. - Common stock (CTNM) SEC filings
CTNM SEC filings moved a median of +0.25% by the close. CTNM SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CTNM overview →
53 measured CTNM SEC filing events.
Where these CTNM SEC filings landedvs 52 measured CTNM SEC filing reactions
| Middle 50% of CTNM SEC filing reactions | -2.02% to +3.58% |
|---|---|
| Median reaction (to close) | +0.25% |
| Measured reactions | 52 |
Point-in-time · zero look-ahead
Half of the 52 CTNM SEC filing events with a measured close landed between -2.02% and +3.58%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Contineum Therapeutics, For: Sep 14 | SEC filing · Form 8-K | -1.80% | -6.15% | |
| Form 8-K Contineum Therapeutics, For: Sep 14 | SEC filing · Form 8-K | +0.84% | +0.44% | |
| Form 10-Q Contineum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.79% | -1.65% | |
| Form 8-K Contineum Therapeutics, For: Jul 30 | SEC filing · Form 8-K | +0.79% | -1.65% | |
| Form 8-K Contineum Therapeutics, For: Jul 13 | SEC filing · Form 8-K | +0.00% | -2.87% | |
| Form 8-K Contineum Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -2.76% | +6.16% | |
| Form 10-Q Contineum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.55% | +3.11% | |
| Form 8-K Contineum Therapeutics, For: May 05 | SEC filing · Form 8-K | -0.55% | +3.11% | |
| Form 8-K Contineum Therapeutics, For: Apr 30 | SEC filing · Form 8-K | -2.19% | -0.08% | |
| Form ARS Contineum Therapeutics, For: Dec 31 | SEC filing · Form ARS | -2.19% | -0.08% | |
| Form DEF 14A Contineum Therapeutics, For: Jun 26 | SEC filing · Form DEF | -2.19% | -0.08% | |
| Form DEFA14A Contineum Therapeutics, | SEC filing · Form DEFA14A | -2.19% | -0.08% | |
| Form 10-K Contineum Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.62% | -5.64% | |
| Form 8-K Contineum Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -4.62% | -5.64% | |
| Form S-8 Contineum Therapeutics, | SEC filing · Form S-8 | -4.62% | -5.64% | |
| Form 8-K Contineum Therapeutics, For: Jan 23 | SEC filing · Form 8-K | +0.00% | +8.89% | |
| Form 8-K Contineum Therapeutics, For: Dec 11 | SEC filing · Form 8-K | +1.78% | +0.26% | |
| Form 8-K Contineum Therapeutics, For: Dec 08 | SEC filing · Form 8-K | +0.81% | -5.68% | |
| Form 8-K Contineum Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +2.00% | -0.23% | |
| Form 10-Q Contineum Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.38% | +3.58% | |
| Form 8-K Contineum Therapeutics, For: Oct 30 | SEC filing · Form 8-K | +0.38% | +3.58% | |
| Form 8-K Contineum Therapeutics, For: Sep 18 | SEC filing · Form 8-K | -0.89% | +0.24% | |
| Form 10-Q Contineum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.91% | +2.43% | |
| Form 8-K Contineum Therapeutics, For: Aug 05 | SEC filing · Form 8-K | -2.91% | +2.43% | |
| Form 8-K Contineum Therapeutics, For: Jun 26 | SEC filing · Form 8-K | +1.25% | +2.75% | |
| Form EFFECT Contineum Therapeutics, | SEC filing · Form EFFECT | -0.28% | -2.10% | |
| Form 10-Q Contineum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.60% | |
| Form 8-K Contineum Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.00% | +2.60% | |
| Form S-3 Contineum Therapeutics, | SEC filing · Form S-3 | +0.00% | +2.60% | |
| Form S-8 Contineum Therapeutics, | SEC filing · Form S-8 | +0.00% | +2.60% | |
| Form ARS Contineum Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | -5.30% | |
| Form DEF 14A Contineum Therapeutics, For: Jun 26 | SEC filing · Form DEF | +0.00% | -5.30% | |
| Form DEFA14A Contineum Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -5.30% | |
| Form 8-K Contineum Therapeutics, For: Apr 28 | SEC filing · Form 8-K | +6.01% | -1.78% | |
| Form 8-K Contineum Therapeutics, For: Mar 14 | SEC filing · Form 8-K | +0.00% | +7.00% | |
| Form 10-K Contineum Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.78% | |
| Form 8-K Contineum Therapeutics, For: Mar 06 | SEC filing · Form 8-K | +0.00% | +5.78% | |
| Form S-8 Contineum Therapeutics, | SEC filing · Form S-8 | +0.00% | +5.78% | |
| Form 10-Q Contineum Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.92% | +6.98% | |
| Form 8-K Contineum Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +0.92% | +6.98% | |
| Form 10-Q Contineum Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -2.76% | |
| Form 8-K/A Contineum Therapeutics, For: Aug 13 | SEC filing · Form 8-K | — | -4.00% | |
| Form 8-K Contineum Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +0.00% | +5.56% | |
| Form 8-K Contineum Therapeutics, For: Jun 21 | SEC filing · Form 8-K | +0.00% | +0.05% | |
| Form 8-K Contineum Therapeutics, For: May 24 | SEC filing · Form 8-K | — | +0.19% | |
| Form 8-K Contineum Therapeutics, For: May 20 | SEC filing · Form 8-K | -0.76% | +1.07% | |
| Form 10-Q Contineum Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +5.08% | |
| Form 8-K Contineum Therapeutics, For: May 16 | SEC filing · Form 8-K | +0.00% | +5.08% | |
| Form SEC STAFF LETTER Contineum Therapeutics, | SEC filing · Form SEC | -0.07% | -3.25% | |
| Form 8-K Contineum Therapeutics, For: Apr 09 | SEC filing · Form 8-K | -1.76% | -1.99% | |
| Form S-8 Contineum Therapeutics, | SEC filing · Form S-8 | -1.76% | -1.99% | |
| Form EFFECT Contineum Therapeutics, | SEC filing · Form EFFECT | -1.38% | +6.21% | |
| Form CERT Contineum Therapeutics, | SEC filing · Form CERT | — | — |
Keep exploring
More CTNM: earnings → · analyst actions → · CTNM overview →